Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury (English, HTML)

View metadata and access the original English HTML file: Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury.

Format

HTML

Access

file-only

Publisher-reported update

2024-05-10

Health Canada reviewed the potential risk of liver injury with Pradaxa after receiving reports of severe liver injury from the manufacturer. The manufacturer was asked to provide all available data on Pradaxa and the risk of liver injury.

Access original file